191 related articles for article (PubMed ID: 1718290)
1. Potential antidepressant activity and enhancement of serotonin uptake of a new dibenzothiadiazepine derivative.
Borsini F; Volterra G; Lecci A; Evangelista S; Mancinelli A; Cutrufo C; Parlani M; Mennini T; Barone D; Meli A
Arzneimittelforschung; 1991 Jun; 41(6):573-80. PubMed ID: 1718290
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and pharmacological evaluation of the novel antidepressant and serotonin uptake inhibitor 2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol hydrochloride.
Gouret CJ; Porsolt R; Wettstein JG; Puech A; Soulard C; Pascaud X; Junien JL
Arzneimittelforschung; 1990 Jun; 40(6):633-40. PubMed ID: 2168703
[TBL] [Abstract][Full Text] [Related]
3. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
4. The central action of carbamazepine as a potential antidepressant drug.
Maj J; Chojnacka-Wójcik E; Lewandowska A; Tatarczyńska E; Wiczyńska B
Pol J Pharmacol Pharm; 1985; 37(1):47-56. PubMed ID: 4041037
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of lortalamine, a new potent non-tricyclic antidepressant.
Depin JC; Betbeder-Matibet A; Bonhomme Y; Muller AJ; Berthelon JJ
Arzneimittelforschung; 1985; 35(11):1655-62. PubMed ID: 4091869
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant profile of 9-methyl-2[-3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro-beta- carbolin-1-one (B-193).
Wiczyńska B; Antkiewicz-Michaluk L; Pilc A; Chojnacka-Wójcik E; Przegaliński E
Pol J Pharmacol Pharm; 1989; 41(4):331-44. PubMed ID: 2636891
[TBL] [Abstract][Full Text] [Related]
7. Norzotepine, a major metabolite of zotepine, exerts atypical antipsychotic-like and antidepressant-like actions through its potent inhibition of norepinephrine reuptake.
Shobo M; Kondo Y; Yamada H; Mihara T; Yamamoto N; Katsuoka M; Harada K; Ni K; Matsuoka N
J Pharmacol Exp Ther; 2010 Jun; 333(3):772-81. PubMed ID: 20223878
[TBL] [Abstract][Full Text] [Related]
8. The involvement of serotonin in the mechanism of central action of apomorphine.
Grabowska M
Pol J Pharmacol Pharm; 1976; 28(4):389-94. PubMed ID: 790347
[TBL] [Abstract][Full Text] [Related]
9. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
[TBL] [Abstract][Full Text] [Related]
10. Some central effects of tiflucarbine, a new potential antidepressant drug.
Maj J; Rogóz Z; Sowińska H; Zalewski Z
Pol J Pharmacol Pharm; 1987; 39(1):63-74. PubMed ID: 2823240
[TBL] [Abstract][Full Text] [Related]
11. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
Koe BK; Weissman A; Welch WM; Browne RG
J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant activities of WEB 1881, a new nootropic agent.
Maj J; Rogóz Z; Skuza G; Sowińska H; Nowak G
Pol J Pharmacol Pharm; 1989; 41(5):439-52. PubMed ID: 2561889
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the involvement of the monoaminergic system in the antidepressant-like action of two 4-amine derivatives of 10,11-dihydro-5H-dibenzo [a,d] cycloheptane in mice evaluated in the tail suspension test.
Duarte FS; Lach G; Martins PR; Romeiro GA; de Lima TC
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):368-74. PubMed ID: 17920179
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of the novel antidepressant 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno-[2,3-d]pyrimidine monohydrate hydrochloride.
Eguchi J; Inomata Y; Yuasa T; Egawa M; Saito K
Arzneimittelforschung; 1997 Dec; 47(12):1337-47. PubMed ID: 9450161
[TBL] [Abstract][Full Text] [Related]
15. Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat.
Mignon L; Wolf WA
Psychopharmacology (Berl); 2002 Aug; 163(1):85-94. PubMed ID: 12185404
[TBL] [Abstract][Full Text] [Related]
16. Behavioural pharmacology of imidazole, a potential antidepressant agent.
Ferrari F
Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):303-12. PubMed ID: 4062441
[TBL] [Abstract][Full Text] [Related]
17. Role for serotonin in the antidepressant-like effect of a flavonoid extract of Xiaobuxin-Tang.
An L; Zhang YZ; Yu NJ; Liu XM; Zhao N; Yuan L; Li YF
Pharmacol Biochem Behav; 2008 Jun; 89(4):572-80. PubMed ID: 18367239
[TBL] [Abstract][Full Text] [Related]
18. The central action of salbutamol, a beta-agonist with a potential antidepressant activity.
Przegalinski E; Baran L; Kedrek G
Pol J Pharmacol Pharm; 1980; 32(4):485-93. PubMed ID: 6265886
[TBL] [Abstract][Full Text] [Related]
19. Central effects of SL 82.0715, an antagonist of polyamine site of the NMDA receptor complex.
Dereń-Wesołek A; Maj J
Pol J Pharmacol; 1993; 45(5-6):467-80. PubMed ID: 7912135
[TBL] [Abstract][Full Text] [Related]
20. [The new versus the old antidepressant drugs: a comparative study of their psychopharmacological profiles (author's transl)].
Bourin M; Puech AJ; Chermat R; Doare L; Poncelet M; Simon P
Encephale; 1981; 7(3):235-42. PubMed ID: 7285851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
